0001209191-17-010892.txt : 20170214
0001209191-17-010892.hdr.sgml : 20170214
20170214201658
ACCESSION NUMBER: 0001209191-17-010892
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170213
FILED AS OF DATE: 20170214
DATE AS OF CHANGE: 20170214
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARENA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001080709
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 232908305
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6154 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-453-7200
MAIL ADDRESS:
STREET 1: 6154 NANCY RIDGE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FETZER OLIVER
CENTRAL INDEX KEY: 0001219018
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-31161
FILM NUMBER: 17612475
MAIL ADDRESS:
STREET 1: AUXILIUM PHARMACEUTICALS, INC.
STREET 2: 40 VALLEY STREAM PARKWAY
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-02-13
0
0001080709
ARENA PHARMACEUTICALS INC
ARNA
0001219018
FETZER OLIVER
C/O ARENA PHARMACEUTICALS, INC.
6154 NANCY RIDGE DRIVE
SAN DIEGO
CA
92121
1
0
0
0
Employee Stock Option (right to buy)
1.46
2017-02-13
4
A
0
75000
0.00
A
2024-02-13
Common Stock
75000
75000
D
Employee Stock Option (right to buy)
1.46
2017-02-13
4
A
0
41666
0.00
A
2024-02-13
Common Stock
41666
41666
D
The options vest over one year with one twelfth vesting on March 13, 2017, and the remainder of the shares vesting monthly over the following eleven months in equal installments (except as otherwise necessary to avoid vesting of a fractional share), and are exercisable once vested.
The options vest over four months with 25% vesting on March 13, 2017, and the remainder of the shares vesting monthly over the following three months in equal installments (except as otherwise necessary to avoid vesting of a fractional share), and are exercisable once vested.
Steven W. Spector, as Attorney-in-Fact
2017-02-14